Abbott Laboratories
Net Cash Flow Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
FY2007
Total Cash from Operations: $3.68B
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $499.1M | 13.6% |
| Business Acquisitions | $1.54B | 41.8% |
| Dividends Paid | $112.3M | 3.1% |
| Stock Repurchases | $183.7M | 5.0% |
| Other | $755.0M | 20.5% |
| Net Cash Flow | $588.0M | 16.0% |